Litcius/Paper detail

Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients

Romain Salle, François Chasset, D. Kottler, C. Picard‐Dahan, A. Jannic, Nour Mekki, T. De Risi-Pugliese, J.‐B. Monfort, A. Barbaud, Camille Françès, V. Descamps

2020Journal of the American Academy of Dermatology32 citationsDOIOpen Access PDF

Topics & Concepts

BelimumabMedicineDermatologyPost-hoc analysisObservational studyMucocutaneous zonePlaceboMonoclonalRefractory (planetary science)Lupus erythematosusPost hocInternal medicineMonoclonal antibodyImmunologyB-cell activating factorAntibodyAlternative medicinePathologyDiseaseB cellPhysicsAstrobiologySystemic Lupus Erythematosus ResearchT-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research
Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients | Litcius